Russell W Creel, NP | |
400 Westwood Dr, Wausau, WI 54401-7801 | |
(414) 325-7246 | |
(414) 325-3770 |
Full Name | Russell W Creel |
---|---|
Gender | Male |
Speciality | Nurse Practitioner |
Location | 400 Westwood Dr, Wausau, Wisconsin |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1134265739 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
363LF0000X | Nurse Practitioner - Family | 71002332A (Indiana) | Secondary |
363L00000X | Nurse Practitioner | 4278 (Wisconsin) | Primary |
Entity Name | Marshfield Clinic Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1952347981 PECOS PAC ID: 2264345206 Enrollment ID: O20031106000590 |
News Archive
Canopus BioPharma Inc. today announces that it has completed crucial research in confirming efficacy of a prescription drug: CB008 for Ebola Virus inhibition.
Researchers using functional magnetic resonance imaging (fMRI) have found a new marker which may aid in early diagnosis of Alzheimer's disease, according to a study published in the October issue of Radiology.
UNISON's call for a time-out in the increased use of markets in the NHS has helped raise public awareness of the issue in the run up to this weekend's NHS Together day of action.
Injection of a novel form of synthetic high-density lipoprotein cholesterol (HDL-C), or good cholesterol, into the arteries of patients who had recently had a heart attack did not reduce the volume of fatty deposits, or plaque, in the arteries, compared with placebo injections, according to research presented at the American College of Cardiology's 66th Annual Scientific Session.
› Verified 6 days ago
Entity Name | Advanced Pain Management Sc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1770506669 PECOS PAC ID: 1456257633 Enrollment ID: O20031209000560 |
News Archive
Canopus BioPharma Inc. today announces that it has completed crucial research in confirming efficacy of a prescription drug: CB008 for Ebola Virus inhibition.
Researchers using functional magnetic resonance imaging (fMRI) have found a new marker which may aid in early diagnosis of Alzheimer's disease, according to a study published in the October issue of Radiology.
UNISON's call for a time-out in the increased use of markets in the NHS has helped raise public awareness of the issue in the run up to this weekend's NHS Together day of action.
Injection of a novel form of synthetic high-density lipoprotein cholesterol (HDL-C), or good cholesterol, into the arteries of patients who had recently had a heart attack did not reduce the volume of fatty deposits, or plaque, in the arteries, compared with placebo injections, according to research presented at the American College of Cardiology's 66th Annual Scientific Session.
› Verified 6 days ago
Entity Name | Mchs Hospitals Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1093221434 PECOS PAC ID: 5698071173 Enrollment ID: O20180208000096 |
News Archive
Canopus BioPharma Inc. today announces that it has completed crucial research in confirming efficacy of a prescription drug: CB008 for Ebola Virus inhibition.
Researchers using functional magnetic resonance imaging (fMRI) have found a new marker which may aid in early diagnosis of Alzheimer's disease, according to a study published in the October issue of Radiology.
UNISON's call for a time-out in the increased use of markets in the NHS has helped raise public awareness of the issue in the run up to this weekend's NHS Together day of action.
Injection of a novel form of synthetic high-density lipoprotein cholesterol (HDL-C), or good cholesterol, into the arteries of patients who had recently had a heart attack did not reduce the volume of fatty deposits, or plaque, in the arteries, compared with placebo injections, according to research presented at the American College of Cardiology's 66th Annual Scientific Session.
› Verified 6 days ago
Entity Name | Lakeview Medical Center Inc Of Rice Lake |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1093201832 PECOS PAC ID: 6103737820 Enrollment ID: O20180817001484 |
News Archive
Canopus BioPharma Inc. today announces that it has completed crucial research in confirming efficacy of a prescription drug: CB008 for Ebola Virus inhibition.
Researchers using functional magnetic resonance imaging (fMRI) have found a new marker which may aid in early diagnosis of Alzheimer's disease, according to a study published in the October issue of Radiology.
UNISON's call for a time-out in the increased use of markets in the NHS has helped raise public awareness of the issue in the run up to this weekend's NHS Together day of action.
Injection of a novel form of synthetic high-density lipoprotein cholesterol (HDL-C), or good cholesterol, into the arteries of patients who had recently had a heart attack did not reduce the volume of fatty deposits, or plaque, in the arteries, compared with placebo injections, according to research presented at the American College of Cardiology's 66th Annual Scientific Session.
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
Russell W Creel, NP 4131 W Loomis Rd Ste 300, Greenfield, WI 53221-2059 Ph: (414) 325-7246 | Russell W Creel, NP 400 Westwood Dr, Wausau, WI 54401-7801 Ph: (414) 325-7246 |
News Archive
Canopus BioPharma Inc. today announces that it has completed crucial research in confirming efficacy of a prescription drug: CB008 for Ebola Virus inhibition.
Researchers using functional magnetic resonance imaging (fMRI) have found a new marker which may aid in early diagnosis of Alzheimer's disease, according to a study published in the October issue of Radiology.
UNISON's call for a time-out in the increased use of markets in the NHS has helped raise public awareness of the issue in the run up to this weekend's NHS Together day of action.
Injection of a novel form of synthetic high-density lipoprotein cholesterol (HDL-C), or good cholesterol, into the arteries of patients who had recently had a heart attack did not reduce the volume of fatty deposits, or plaque, in the arteries, compared with placebo injections, according to research presented at the American College of Cardiology's 66th Annual Scientific Session.
› Verified 6 days ago
Ms. Jacquelyn Forbes Kearns, MS,ARNP-C Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 2727 Plaza Dr, Wausau, WI 54401 Phone: 715-847-3000 | |
Alicia Schumacher, AANPCP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 520 N 32nd Ave, Wausau, WI 54401 Phone: 715-847-2424 | |
Kyla P Teresinski, APNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 510 N 17th Ave Ste C, Wausau, WI 54401 Phone: 715-849-5333 Fax: 715-849-4083 | |
Marietta S Kern, APNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 218 N 28th Ave, Wausau, WI 54401 Phone: 715-847-2866 | |
Bradley A Mueller, APNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 225000 Hummingbird Rd Ste 100, Wausau, WI 54401 Phone: 715-359-6442 Fax: 715-393-0390 | |
Gina E Ramthun, APNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1901 Westwood Center Blvd, Wausau, WI 54401 Phone: 715-355-9424 | |
Tiffany Pluger, PMHNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 2400 Marshall St Ste A, Wausau, WI 54403 Phone: 715-848-4356 Fax: 715-845-5398 |